MicroRNA-200a inhibits cell proliferation by targeting mitochondrial transcription factor a in breast cancer

DNA and Cell Biology

Volumn 33, Issue 5, 2014, Pages 291-300

  Yao, Jia ^a   Zhou, Enxiang ^a   Wang, Yichun ^b   Xu, Feng ^a   Zhang, Danhua ^a   Zhong, Dewu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA 200A; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL LINE; CANCER TISSUE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE DOSAGE; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; MCF 7 CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

BREAST NEOPLASMS; CELL PROLIFERATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICRORNAS; MITOCHONDRIAL PROTEINS; PROTEIN BINDING; TRANSCRIPTION FACTORS;

EID: 84899730685     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2132     Document Type: Article

References (52)

1. Ambros, V. (2004). The functions of animal microRNAs. Nature 431, 350-355.
2. Bracken, C.P., Gregory, P.A., Kolesnikoff, N., Bert, A.G., Wang, J., et al. (2008). A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelialmesenchymal transition. Cancer Res 68, 7846-7854.
3. Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., et al. (2008). A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9, 582-589.
4. Bonawitz, N.D., Clayton, D.A., and Shadel, G.S. (2006). Initiation and beyond: multiple functions of the human mitochondrial transcription machinery. Mol Cell 24, 813-825.
5. Baffy, G. (2010). Uncoupling protein-2 and cancer, Mitochondrion 10, 243-252.
6. Bin H., Hiroto I., Yoshihiro Y., Masaki A., Takahiro Y., et al. (2011). Human mitochondrial transcription factor A functions in both nuclei and mitochondria and regulates cancer cell growth. Biochem Biophys Res Commun 408, 45-51.
7. Bonner, M.R., Shen, M., Liu, C.S., Divita, M., He, X., and Lan, Q. (2009). Mitochondrial DNA content and lung cancer risk in Xuan Wei, China. Lung Cancer 63, 331-334.
8. Calin, G.A., and Croce, C.M. (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6, 857-866.
9. Cochrane, D.R., Howe, E.N., Spoelstra, N.S., and Richer, J.K. (2010). Loss of miR-200c: a marker of aggressiveness and chemoresistance in female reproductive cancers. J Oncol 2010, 821717.
10. Chen T., He J., Shen L., et al. (2011). The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer. BMC Med Genet 12, 8.
11. Chinnery, P.F., Elliott, H.R., Hudson, G., Samuels, D.C., and Relton, C.L. (2012). Epigenetics, epidemiology and mitochondrial DNA diseases. Int J Epidemiol 41, 177-187.
12. Egan K., Kusao I., Troelstrup D., Agsalda, M., and Shiramizu, B. (2010). Mitochondrial DNA in residual leukemia cells in cerebrospinal fluid in children with acute lymphoblastic leukemia. J Clin Med Res 2, 225-229.
13. Feng, S. Xiong, L., Ji, Z., Cheng, W., and Yang, H. (2011). Correlation between increased copy number of mitochondrial DNA and clinicopathological stage in colorectal cancer. Oncol Lett 2, 899-903.
14. Feng, S., Xiong, L., Ji, Z., Cheng, W., and Yang, H. (2012). Correlation between increased ND2 expression and demethylated displacement loop of mtDNA in colorectal cancer. Mol Med Rep 6, 125-130.
15. Gregory, P.A., Bert, A.G., Paterson, E.L., Barry, S.C., Tsykin, A., et al. (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10, 593-601.
16. Guarneri, V., and Conte, P. (2009). Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy. Oncologist 14, 645-656.
17. Guo, J., Zheng, L., Liu, W., et al. (2011). Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer. Cancer Res 71, 2978-2987.
18. Han, B., Izumi, H., Yasuniwa, Y., et al. (2011). Human mitochondrial transcription factor A functions in both nuclei and mitochondria and regulates cancer cell growth. Biochem Biophys Res Commun 408, 45-51.
19. He, L., and Hannon, G.J. (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5, 522-531.
20. Hung, C.S., Liu, H.H., Liu, J.J., Yeh, C.T., Chang, T.C., et al. (2013). MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers. Ann Surg Oncol Suppl 3:S360-8. [Epub ahead of print]; DOI: 10.1245/s10434-012-2482-4.
21. Hyun, S., Lee, J.H., Jin, H., Nam, J., Namkoong, B., et al. (2009). Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K. Cell 139, 1096-1108.
22. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., et al. (2009). Cancer statistics. CA Cancer J Clin 59, 225-249.
23. Jonathon, D.R, Yi Z., Young-Ho A., Yanan Y., et al. (2011). miR-200 inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VCOX21. Mol Cancer Res 9, 25-35.
24. Kurashige, J., Kamohara, H., Watanabe, M., Hiyoshi, Y., Iwatsuki, M., et al. (2012). MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol 19 Suppl 3, S656-S664.
25. Korpal, M., Lee, E.S., Hu, G., and Kang, Y. (2008). The miR- 200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283, 14910-14914.
26. Krell, J., Frampton, A.E., and Stebbing, J. (2013). MicroRNAs in the cancer clinic. Front Biosci (Elite Ed) 5, 204-213.
27. Kusao I., Agsalda M., Troelstrup D., Villanueva, N., and Shiramizu, B. (2008). Chemotoxicity recovery of mitochondria in non-Hodgkin lymphoma resulting in minimal residual disease. Pediatr Blood Cancer 51, 193-197.
28. Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A., Downing, J.R. et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834-838.
29. Lim, L.P., Lau, N.C., Garrett-Engele, P., Grimson, A., Schelter, J.M., Castle, J., Bartel, D.P., Linsley, P.S., and Johnson, J.M. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773.
30. Lee, H.C., and Wei, Y.H. (2009). Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci 10, 674-701.
31. Larsson, N.G., Wang, J., Wilhelmsson, H., Oldfors, A., Rustin, P., ewandoski, M., Barsh, G.S., and Clayton, D.A. (1998). Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis inmice. NatGenet 18, 231-236.
32. Luciakova, K., and Kuzela, S. (1992). Increased steady-state levels of several mitochondrial and nuclear gene transcripts in rat hepatoma with a low content of mitochondria. Eur J Biochem 205, 1187-1193.
33. Mayevsky, A. (2009). Mitochondrial function and energy metabolism in cancer cells: past overview and future perspectives, Mitochondrion 9, 165-179.
34. Mambo, E., Chatterjee, A., Xing, M., et al. (2005). Tumorspecific changes in mtDNA content in human cancer. Int J Cancer 116, 920-924.
35. Mizumachi, T., Muskhelishvili, L., Naito, A., et al. (2008). Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells. Prostate 68, 408-417.
36. Manavalan, T.T., Teng, Y., Appana, S.N., Datta, S., Kalbfleisch, T.S., et al. (2011). Differential expression of micro-RNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells. Cancer Lett 313, 26-43.
37. Osaki, M., Takeshita, F., Sugimoto, Y., Kosaka, N., Yamamoto, Y., Yoshioka, Y., Kobayashi, E., Yamada, T., Kawai, A., Inoue, T., Ito, H., et al. (2011). MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease- 13 expression. Mol Ther 19, 1123-1130.
38. Park, S.M., Gaur, A.B., Lengyel, E., and Peter, M.E. (2008). The miR-200 family determines the epithelial phenotype of cancer cells by targeting the Ecadherin repressors ZEB1 and ZEB2. Genes Dev 22, 894-907.
39. Penta, J.S., Johnson, F.M., Wachsman, J.T., and Copeland, W.C. (2001). Mitochondrial DNA in human malignancy. Mutat Res 488, 119-133.
40. Qu, F., Liu, X., Zhou, F., et al. (2011). Association between mitochondrial DNA content in leukocytes and colorectal cancer risk: a case-control analysis. Cancer 117, 3148-3155.
41. Radojicic, J., Zaravinos, A., Vrekoussis, T., Kafousi, M., Spandidos, D.A., Stathopoulos, E.N. (2011). MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer. Cell Cycle 10, 507-517.
42. Rasheed, S.A., Teo, C.R., Beillard, E.J., Voorhoeve, P.M., and Casey, P.J. (2013). MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells. J Biol Chem 288, 7986-7995.
43. Stefani, G., and Slack, F.J. (2008). Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9, 219-230.
44. Schickel, R., Boyerinas, B., Park, S.M., and Peter, M.E. (2008). MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27, 5959-5974.
45. Shen, J., Platek, M., Mahasneh, A., Ambrosone, C.B., and Zhao, H. (2010). Mitochondrial copy number and risk of breast cancer: a pilot study. Mitochondrion 10, 62-68.
46. Samudio, I., Fiegl, M., and Andreeff, M. (2009). Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. Cancer Res 69, 2163-2166.
47. Takamatsu, C., Umeda, S., Ohsato, T., Ohno, T., Abe, Y., et al. (2002). Regulation of mitochondrial D-loops by transcription factor A and single-stranded DNA-binding protein. EMBO Rep 3, 451-456.
48. Thyagarajan, B., Wang, R., Barcelo, H., Koh, W.P., and Yuan, J.M. (2012). Mitochondrial copy number is associated with colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 21, 1574-1581.
49. Uhlmann, S., Zhang, J.D., Schwager, A., Mannsperger, H., Riazalhosseini, Y., et al. (2010). miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene 29, 4297-4306.
50. Virbasius, J.V., and Scarpulla, R.C. (1994). Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc Natl Acad Sci U S A 91, 1309-1313.
51. Weinberg, F., Hamanaka, R., Wheaton, W.W., Weinberg, S., Joseph, J. et al. (2010). Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A 107, 8788-8793.
52. Zhang, L., Yang, F., Yuan, J.H., Yuan, S.X., Zhou, W.P., et al. (2013). Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 34, 577-586.